Literature DB >> 16142674

Immune reconstitution syndrome due to bacillus Calmette-Guérin after initiation of antiretroviral therapy in children with HIV infection.

Thanyawee Puthanakit1, Penninah Oberdorfer, Suchart Punjaisee, Pornphun Wannarit, Thira Sirisanthana, Virat Sirisanthana.   

Abstract

The immune reconstitution syndrome caused by bacillus Calmette-Guerin (BCG) was found in 4 HIV-infected children who were immunized with BCG at birth. The localized, suppurative, BCG-related complications developed within 10 weeks after initiation of antiretroviral therapy. The incidence rate was 2.7 cases per 100 persons (95% confidence interval, 0.7-6.7). Patients responded well to treatment with isoniazid and rifampicin.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16142674      PMCID： PMC1924528          DOI： 10.1086/433177

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  16 in total

Review 1.  Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2000-04       Impact factor: 21.405

2.  National study of adverse reactions after vaccination with bacille Calmette-Guérin.

Authors:  F M Turnbull; P B McIntyre; H M Achat; H Wang; R Stapledon; M Gold; M A Burgess
Journal:  Clin Infect Dis       Date:  2002-01-04       Impact factor: 9.079

Review 3.  Immune reconstitution inflammatory syndrome: emergence of a unique syndrome during highly active antiretroviral therapy.

Authors:  Samuel A Shelburne; Richard J Hamill; Maria C Rodriguez-Barradas; Stephen B Greenberg; Robert L Atmar; Daniel W Musher; Joseph C Gathe; Fehmida Visnegarwala; Barbara W Trautner
Journal:  Medicine (Baltimore)       Date:  2002-05       Impact factor: 1.889

Review 4.  Bacille Calmette-Guérin lymphadenitis.

Authors:  Jafinder S Goraya; V S Virdi
Journal:  Postgrad Med J       Date:  2002-06       Impact factor: 2.401

5.  PCR identification of Mycobacterium bovis BCG.

Authors:  E A Talbot; D L Williams; R Frothingham
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

6.  Regional Bacillus Calmette-Guérin lymphadenitis after initiating antiretroviral therapy in an infant with human immunodeficiency virus type 1 infection.

Authors:  M J Sharp; D F Mallon
Journal:  Pediatr Infect Dis J       Date:  1998-07       Impact factor: 2.129

Review 7.  Disseminated bacille Calmette-Guérin disease after vaccination: case report and review.

Authors:  E A Talbot; M D Perkins; S F Silva; R Frothingham
Journal:  Clin Infect Dis       Date:  1997-06       Impact factor: 9.079

8.  Bacteremia due to Mycobacterium tuberculosis or M. bovis, Bacille Calmette-Guérin (BCG) among HIV- positive children and adults in Zambia.

Authors:  R D Waddell; K Lishimpi; C F von Reyn; C Chintu; K S Baboo; B Kreiswirth; E A Talbot; M R Karagas
Journal:  AIDS       Date:  2001-01-05       Impact factor: 4.177

Review 9.  Immunization of children at risk of infection with human immunodeficiency virus.

Authors:  William J Moss; C John Clements; Neal A Halsey
Journal:  Bull World Health Organ       Date:  2003-03-11       Impact factor: 9.408

10.  The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature.

Authors:  G A Colditz; C S Berkey; F Mosteller; T F Brewer; M E Wilson; E Burdick; H V Fineberg
Journal:  Pediatrics       Date:  1995-07       Impact factor: 7.124
View more
  18 in total

1.  Pediatric HIV immune reconstitution inflammatory syndrome.

Authors:  David R Boulware; Steven Callens; Savita Pahwa
Journal:  Curr Opin HIV AIDS       Date:  2008-07       Impact factor: 4.283

2.  Early antiretroviral treatment reduces risk of bacille Calmette-Guérin immune reconstitution adenitis.

Authors:  H Rabie; A Violari; T Duong; S A Madhi; D Josipovic; S Innes; E Dobbels; E Lazarus; R Panchia; A G Babiker; D M Gibb; M F Cotton
Journal:  Int J Tuberc Lung Dis       Date:  2011-09       Impact factor: 2.373

3.  Immune reconstitution syndrome from nontuberculous mycobacterial infection after initiation of antiretroviral therapy in children with HIV infection.

Authors:  Thanyawee Puthanakit; Peninnah Oberdorfer; Nuthapong Ukarapol; Noppadon Akarathum; Suchart Punjaisee; Thira Sirisanthana; Virat Sirisanthana
Journal:  Pediatr Infect Dis J       Date:  2006-07       Impact factor: 2.129

4.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

5.  Disseminated Bacillus Calmette-Guérin (BCG) infection following allogeneic hematopoietic stem cell transplant in a patient with Bare Lymphocyte Syndrome type II.

Authors:  R F Abu-Arja; B E Gonzalez; M R Jacobs; L Cabral; R Egler; J Auletta; J Arnold; K R Cooke
Journal:  Transpl Infect Dis       Date:  2014-07-04       Impact factor: 2.228

6.  Reduced rate of adverse reactions to the BCG vaccine in children exposed to the vertical transmission of HIV infection and in HIV-infected children from an endemic setting in Brazil.

Authors:  Regina Célia de Souza Campos Fernandes; Luciana Cordeiro de Araújo; Enrique Medina-Acosta
Journal:  Eur J Pediatr       Date:  2008-09-03       Impact factor: 3.183

7.  Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  Lynne M Mofenson; Michael T Brady; Susie P Danner; Kenneth L Dominguez; Rohan Hazra; Edward Handelsman; Peter Havens; Steve Nesheim; Jennifer S Read; Leslie Serchuck; Russell Van Dyke
Journal:  MMWR Recomm Rep       Date:  2009-09-04

8.  Immune reconstitution inflammatory syndrome among HIV-infected South African infants initiating antiretroviral therapy.

Authors:  Kelly Smith; Louise Kuhn; Ashraf Coovadia; Tammy Meyers; Chih-Chi Hu; Cordula Reitz; Gillian Barry; Renate Strehlau; Gayle Sherman; Elaine J Abrams
Journal:  AIDS       Date:  2009-06-01       Impact factor: 4.177

9.  BCG vaccination in South African HIV-exposed infants--risks and benefits.

Authors:  A C Hesseling; J Caldwell; M F Cotton; B S Eley; H B Jaspan; K Jennings; B J Marais; J Nuttall; H Rabie; P Roux; H S Schaaf
Journal:  S Afr Med J       Date:  2009-02

Review 10.  BCG: a vaccine with multiple faces.

Authors:  Marco Antonio Yamazaki-Nakashimada; Alberto Unzueta; Luisa Berenise Gámez-González; Napoleón González-Saldaña; Ricardo U Sorensen
Journal:  Hum Vaccin Immunother       Date:  2020-01-29       Impact factor: 3.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.